164 related articles for article (PubMed ID: 9873555)
1. Synthesis of 6-O-methyl-azithromycin and its ketolide analogue via Beckmann rearrangement of 9(E)-6-O-methyl-erythromycin oxime.
Denis A; Agouridas C
Bioorg Med Chem Lett; 1998 Sep; 8(18):2427-32. PubMed ID: 9873555
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of the new ketolide HMR 3004 compared to an azalide and macrolides against Streptococcus pneumoniae and Haemophilus influenzae.
Barry AL; Fuchs PC; Brown SD
Eur J Clin Microbiol Infect Dis; 1997 Oct; 16(10):767-9. PubMed ID: 9405952
[TBL] [Abstract][Full Text] [Related]
3. Comparative antimicrobial activity of ABT-773, a novel ketolide, tested against drug-resistant Gram-positive cocci and Haemophilus influenzae.
Rospide MF; Biedenbach DJ; Jones RN
Int J Antimicrob Agents; 2001 Jun; 17(6):451-5. PubMed ID: 11397614
[TBL] [Abstract][Full Text] [Related]
4. Novel hybrids of 15-membered 8a- and 9a-azahomoerythromycin A ketolides and quinolones as potent antibacterials.
Pavlović D; Fajdetić A; Mutak S
Bioorg Med Chem; 2010 Dec; 18(24):8566-82. PubMed ID: 21055953
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antibacterial activity of ketolides (6-O-methyl-3-oxoerythromycin derivatives): a new class of antibacterials highly potent against macrolide-resistant and -susceptible respiratory pathogens.
Agouridas C; Denis A; Auger JM; Benedetti Y; Bonnefoy A; Bretin F; Chantot JF; Dussarat A; Fromentin C; D'Ambrières SG; Lachaud S; Laurin P; Le Martret O; Loyau V; Tessot N
J Med Chem; 1998 Oct; 41(21):4080-100. PubMed ID: 9767644
[TBL] [Abstract][Full Text] [Related]
6. Comparative in vitro activity of ABT-773, a novel antibacterial ketolide.
Nilius AM; Bui MH; Almer L; Hensey-Rudloff D; Beyer J; Ma Z; Or YS; Flamm RK
Antimicrob Agents Chemother; 2001 Jul; 45(7):2163-8. PubMed ID: 11408246
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and antibacterial activity of novel 11-[3-[(arylcarbamoyl)oxy]propylamino]-11-deoxy-6-O-methyl-3-oxoerythromycin A 11-N,12-O-cyclic carbamate derivatives.
Zheng Z; Du D; Cao L; Liu J; Chen X
J Antibiot (Tokyo); 2016 Nov; 69(11):811-817. PubMed ID: 27118243
[TBL] [Abstract][Full Text] [Related]
8. In vitro activities of the ketolides ABT-773 and telithromycin and of three macrolides against genetically characterized isolates of Streptococcus pneumoniae, Streptococcus pyogenes, Haemophilus influenzae and Moraxella catarrhalis.
Schmitz FJ; Schwarz S; Milatovic D; Verhoef J; Fluit AC
J Antimicrob Chemother; 2002 Jul; 50(1):145-8. PubMed ID: 12096026
[No Abstract] [Full Text] [Related]
9. Antibacterial activity of telithromycin (HMR 3647) in relation to in vitro simulated human plasma kinetics.
Bonnefoy A; Le Priol P
J Antimicrob Chemother; 2001 Apr; 47(4):471-3. PubMed ID: 11266424
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and antibacterial activity of HMR 3647 a new ketolide highly potent against erythromycin-resistant and susceptible pathogens.
Denis A; Agouridas C; Auger JM; Benedetti Y; Bonnefoy A; Bretin F; Chantot JF; Dussarat A; Fromentin C; D'Ambrières SG; Lachaud S; Laurin P; Le Martret O; Loyau V; Tessot N; Pejac JM; Perron S
Bioorg Med Chem Lett; 1999 Nov; 9(21):3075-80. PubMed ID: 10560728
[TBL] [Abstract][Full Text] [Related]
11. A simple method for deprotection of the N- and O-carbobenzoxy groups and N-methylation of the desosamine sugar moiety of ketolides. Application to the synthesis of ketolide analogues with various 9-iminoether moieties and their antibacterial activities.
Iwaki T; Nomura T; Narukawa Y; Uotani K
J Antibiot (Tokyo); 2005 Nov; 58(11):679-85. PubMed ID: 16466021
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and structure-activity relationships of novel 8a-aza-8a-homoerythromycin A ketolides.
Pavlović D; Mutak S
J Med Chem; 2010 Aug; 53(15):5868-80. PubMed ID: 20684614
[TBL] [Abstract][Full Text] [Related]
13. Ketolides lack inducibility properties of MLS(B) resistance phenotype.
Bonnefoy A; Girard AM; Agouridas C; Chantot JF
J Antimicrob Chemother; 1997 Jul; 40(1):85-90. PubMed ID: 9249208
[TBL] [Abstract][Full Text] [Related]
14. Preferential inhibition of protein synthesis by ketolide antibiotics in Haemophilus influenzae cells.
Champney WS; Tober CL
Curr Microbiol; 2003 Feb; 46(2):103-8. PubMed ID: 12520364
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and antibacterial activity of the tricyclic ketolides TE-802 and its analogs.
Kashimura M; Asaka T; Misawa Y; Matsumoto K; Morimoto S
J Antibiot (Tokyo); 2001 Aug; 54(8):664-78. PubMed ID: 11592503
[TBL] [Abstract][Full Text] [Related]
16. Azalides from azithromycin to new azalide derivatives.
Mutak S
J Antibiot (Tokyo); 2007 Feb; 60(2):85-122. PubMed ID: 17420561
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of the ketolide ABT-773.
Barry AL; Fuchs PC; Brown SD
Antimicrob Agents Chemother; 2001 Oct; 45(10):2922-4. PubMed ID: 11557491
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and antibacterial activity of novel 4″-O-(1-aralkyl-1,2,3-triazol-4-methyl-carbamoyl) azithromycin analogs.
Wang Y; Cong C; Chai WC; Dong R; Jia L; Song D; Zhou Z; Ma S
Bioorg Med Chem Lett; 2017 Aug; 27(16):3872-3877. PubMed ID: 28655423
[TBL] [Abstract][Full Text] [Related]
19. Activities of two novel macrolides, GW 773546 and GW 708408, compared with those of telithromycin, erythromycin, azithromycin, and clarithromycin against Haemophilus influenzae.
Kosowska K; Credito K; Pankuch GA; Hoellman D; Lin G; Clark C; Dewasse B; McGhee P; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 2004 Nov; 48(11):4113-9. PubMed ID: 15504829
[TBL] [Abstract][Full Text] [Related]
20. In-vitro activity of HMR 3647 against Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis and beta-haemolytic streptococci.
Wootton M; Bowker KE; Janowska A; Holt HA; MacGowan AP
J Antimicrob Chemother; 1999 Oct; 44(4):445-53. PubMed ID: 10588304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
